NICE endorses Neuraxpharm’s ublituximab for treating MS
New antibody therapy shows promise in managing condition Neuraxpharm Group has announced that the National Institute for Health and Care...
adminph
First single-dose medicine for P. vivax malaria prequalified by WHO and included in WHO Guidelines
GSK plc (LSE/NYSE: GSK) and Medicines for Malaria Venture (MMV) announced that the World Health Organization (WHO) has awarded prequalification...
Antag Therapeutics secures €80 million in weight loss therapy financing
Versant Ventures leads investment round to advance drug Antag Therapeutics has announced the closing of an €80 million Series A...
Everest therapy shows promise in nephropathy trial
Data highlights effectiveness of EVER001 in treating pMN Everest Medicines has announced promising results from the Phase 1b/2a clinical trial...
Unexpected discovery revives abandoned breast cancer treatment
A new study led by Lund University in Sweden has solved a years-old mystery: which patients with aggressive breast cancer...
KIMMTRAK recommended for funding by NICE for uveal melanoma patients
Immunocore has announced that Kimmtrak (tebentafusp) has been recommended for funding in England by the National Institute for Health and...
Orbit Discovery and Evergreen Theragnostics expand research collaboration
Partnership aims to develop new radiopharmaceuticals for cancer treatment Orbit Discovery, based in Oxford, UK, and Evergreen Theragnostics, headquartered in...
Gluing treatment to cancer
Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA),...
OGT launches enhanced genetic profiling panel for CLL
New SureSeq CLL + CNV V3 panel improves understanding of CLL OGT has announced the launch of its enhanced SureSeq...
Pharma giants vie for oral GLP-1R approval
Race to create first oral drug for obesity intensifies The competition to gain approval for the first oral GLP-1R drug...
Common heart drug may slow progression of Huntington's disease
A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of...
NIH-developed AI algorithm successfully matches potential volunteers to clinical trials release
Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the...
New injection offers hope for asthma and COPD attacks
Injection significantly reduces need for further treatment A new treatment for asthma and COPD attacks could revolutionise patient care, scientists...
UK grants promising innovative medicine status to CIDP drug
Therapy for autoimmune disorder shows potential Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status...
AI can predict study results better than human experts
Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately...
Rab Prinjha
Curve Therapeutics has appointed Rab Prinjha as Chief R&D Officer Curve Therapeutics has appointed Rab Prinjha as Chief Research and Development (R&D) Officer. Rab is a...
Code makers
2024 ABPI Code update has launched – what’s next for pharma and QR codes? The long-anticipated update to the ABPI...
To be precise
How oncology therapies can stand out in a diverse, uncertain landscape The oncology field is rapidly evolving, particularly with the...
Mind the gap
How industry and the NHS can work together to bridge the diagnostic gap in COPD Lord Darzi’s recent report on...
Pfizer announces new Chief Scientific Officer and President, Research & Development
Pfizer Inc. (NYSE: PFE) announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff,...
